Network analysis reveals a signaling regulatory loop in pik3ca-mutated breast predicting survival outcome

Download
  1. (PDF, 666 KB)
  2. Get@NRC: Network analysis reveals a signaling regulatory loop in pik3ca-mutated breast predicting survival outcome (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1016/j.gpb.2017.02.002
AuthorSearch for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleGenomics, Proteomics and Bioinformatics
ISSN1672-0229
2210-3244
Volume15
Issue2
Pages121129
Subjectnetwork analysis; PIK3CA mutation; network motif; breast cancer; genome sequencing; survival
AbstractMutated genes are rarely common even in the same pathological type between cancer patients and as such, it has been very challenging to interpret genome sequencing data and difficult to predict clinical outcomes. PIK3CA is one of a few genes whose mutations are relatively popular in tumors. For example, more than 46.6% of luminal-A breast cancer samples have PIK3CA mutated, whereas only 35.5% of all breast cancer samples contain PIK3CA mutations. To understand the function of PIK3CA mutations in luminal A breast cancer, we applied our recently-proposed Cancer Hallmark Network Framework to investigate the network motifs in the PIK3CA-mutated luminal A tumors. We found that more than 70% of the PIK3CA-mutated luminal A tumors contain a positive regulatory loop where a master regulator (PDGF-D), a second regulator (FLT1) and an output node (SHC1) work together. Importantly, we found the luminal A breast cancer patients harboring the PIK3CA mutation and this positive regulatory loop in their tumors have significantly longer survival than those harboring PIK3CA mutation only in their tumors. These findings suggest that the underlying molecular mechanism of PIK3CA mutations in luminal A patients can participate in a positive regulatory loop, and furthermore the positive regulatory loop (PDGF-D/FLT1/SHC1) has a predictive power for the survival of the PIK3CA-mutated luminal A patients.
Publication date
PublisherElsevier
LanguageEnglish
AffiliationHuman Health Therapeutics; National Research Council Canada
Peer reviewedYes
NPARC number23002172
Export citationExport as RIS
Report a correctionReport a correction
Record identifier030e087c-cb8a-4388-835b-bd4c38f96236
Record created2017-08-29
Record modified2017-08-29
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)